| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |